A Comparative Diagnostic Efficacy of High-Sensitivity versus Rapid Troponin Testing in Acute Myocardial Infarction
DOI:
https://doi.org/10.46966/msjar.v6i3.323Keywords:
Troponin I; Myocardial Infarction; Diagnostic Tests, Routine; Point-of-Care Testing; Sensitivity and SpecificityAbstract
Background: Rapid and accurate diagnosis of acute myocardial infarction (AMI) is critical. While high-sensitivity cardiac troponin (hs-cTn) assays are the contemporary standard, rapid qualitative troponin tests offer speed and simplicity, though their diagnostic performance in direct comparison remains a key clinical question. Objective: This study aimed to compare the diagnostic efficacy of a contemporary hs-cTn assay with a qualitative rapid troponin test in patients presenting with suspected acute coronary syndrome (ACS). Materials and Methods: A cross-sectional study was conducted on 100 patients with suspected ACS. All patients underwent simultaneous testing with a quantitative hs-cTnI assay (gold standard) and a qualitative rapid troponin test (detection threshold: 0.5 ng/mL). Diagnostic performance including sensitivity, specificity, and predictive values—was calculated for the rapid test against the hs-cTn reference. Results: The hs-cTn assay demonstrated 100% sensitivity and specificity. In contrast, the rapid troponin test showed perfect specificity (100%) and positive predictive value (100%), but a critically low sensitivity of 32.8%. It produced 43 false-negative results, yielding a negative predictive value of 46% and an overall diagnostic efficiency of only 57%. Conclusion: The high-sensitivity troponin assay is vastly superior for the early diagnosis of AMI, enabling reliable rule-in and rule-out protocols. The rapid troponin test's poor sensitivity renders it unsuitable as a standalone diagnostic tool in the emergency evaluation of suspected AMI, due to an unacceptably high rate of missed diagnoses.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Yasir A. Abdul-Nabi, Qasim H. Khalaf , Sadiq J. Obaid, Mahdi Murshd Thuwaini
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
